知识 首页 人类健康 知识 All 观点 论文 科普 面谈 过滤 Therapeutic areas COVID-19 消化健康 Apply 首页 人类健康 知识 Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate 首页 人类健康 知识 Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2 首页 人类健康 知识 Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2 首页 人类健康 知识 RBDCOV Talks HIPRA’s participation: In 5 minutes, what is a recombinant protein vaccine? 首页 人类健康 知识 Humoral immune response against XBB.1.5 and BQ.1.1 SARS-CoV-2 variants of a fourth dose of PHH-1V vaccine in adult subjects 首页 人类健康 知识 RBDCOV: The project’s origins and future endeavours 首页 人类健康 知识 Reactogenicity of third and fourth booster doses of HIPRA PHH-1V, a bivalent recombinant protein vaccine against SARS-CoV-2 首页 人类健康 知识 Humoral immune response against SARS-CoV-2 variants of PHH-1V booster vaccine in subjects previously vaccinated with a mRNA vaccine 首页 人类健康 知识 One-year humoral response of PHH-1V booster vaccine in subjects previously vaccinated against COVID-19 with a mRNA vaccine 加载更多